326 related articles for article (PubMed ID: 35530346)
21. Endometrial Cancer: Who Lives, Who Dies, Can We Improve Their Story?
Cosgrove CM; Backes FJ; O'Malley D; Bixel KL; Suarez AA; Fowler JM; Copeland LJ; Goodfellow PJ; Cohn DE
Oncologist; 2021 Dec; 26(12):1044-1051. PubMed ID: 34402130
[TBL] [Abstract][Full Text] [Related]
22. A Timely Update of Immunohistochemistry and Molecular Classification in the Diagnosis and Risk Assessment of Endometrial Carcinomas.
Wang M; Hui P
Arch Pathol Lab Med; 2021 Nov; 145(11):1367-1378. PubMed ID: 34673912
[TBL] [Abstract][Full Text] [Related]
23. Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumours.
Cochrane DR; Campbell KR; Greening K; Ho GC; Hopkins J; Bui M; Douglas JM; Sharlandjieva V; Munzur AD; Lai D; DeGrood M; Gibbard EW; Leung S; Boyd N; Cheng AS; Chow C; Lim JL; Farnell DA; Kommoss S; Kommoss F; Roth A; Hoang L; McAlpine JN; Shah SP; Huntsman DG
J Pathol; 2020 Oct; 252(2):201-214. PubMed ID: 32686114
[TBL] [Abstract][Full Text] [Related]
24. [Increasingly better diagnosis and treatment of endometrial cancer].
Salehi S; Stålberg K; Marcickiewicz J; Rosenberg P; Falconer H
Lakartidningen; 2015 Dec; 112():. PubMed ID: 26646959
[TBL] [Abstract][Full Text] [Related]
25. Endometrial biomarkers for the non-invasive diagnosis of endometriosis.
Gupta D; Hull ML; Fraser I; Miller L; Bossuyt PM; Johnson N; Nisenblat V
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD012165. PubMed ID: 27094925
[TBL] [Abstract][Full Text] [Related]
26. Endometrial cancer.
Crosbie EJ; Kitson SJ; McAlpine JN; Mukhopadhyay A; Powell ME; Singh N
Lancet; 2022 Apr; 399(10333):1412-1428. PubMed ID: 35397864
[TBL] [Abstract][Full Text] [Related]
27. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
Lai J; Xu T; Yang H
BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
[TBL] [Abstract][Full Text] [Related]
28. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
29. A novel risk score system of immune genes associated with prognosis in endometrial cancer.
Zhou H; Zhang C; Li H; Chen L; Cheng X
Cancer Cell Int; 2020; 20():240. PubMed ID: 32549787
[TBL] [Abstract][Full Text] [Related]
30. Combination of Proactive Molecular Risk Classifier for Endometrial cancer (ProMisE) with sonographic and demographic characteristics in preoperative prediction of recurrence or progression of endometrial cancer.
Eriksson LSE; Nastic D; Lindqvist PG; Imboden S; Järnbert-Pettersson H; Carlson JW; Epstein E
Ultrasound Obstet Gynecol; 2021 Sep; 58(3):457-468. PubMed ID: 33314410
[TBL] [Abstract][Full Text] [Related]
31. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
[TBL] [Abstract][Full Text] [Related]
32. Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer.
Stiekema A; Lok C; Korse CM; van Driel WJ; van der Noort V; Kenter GG; Van de Vijver KK
Virchows Arch; 2017 Jun; 470(6):655-664. PubMed ID: 28401338
[TBL] [Abstract][Full Text] [Related]
33. Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology.
Muinelo-Romay L; Casas-Arozamena C; Abal M
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087246
[TBL] [Abstract][Full Text] [Related]
34. An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer.
Zhang J; Wang Z; Zhao R; An L; Zhou X; Zhao Y; Wang H
BMC Cancer; 2020 Oct; 20(1):1030. PubMed ID: 33109128
[TBL] [Abstract][Full Text] [Related]
35. Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?
Ramon-Patino JL; Ruz-Caracuel I; Heredia-Soto V; Garcia de la Calle LE; Zagidullin B; Wang Y; Berjon A; Lopez-Janeiro A; Miguel M; Escudero J; Gallego A; Castelo B; Yebenes L; Hernandez A; Feliu J; Pelaez-García A; Tang J; Hardisson D; Mendiola M; Redondo A
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205661
[TBL] [Abstract][Full Text] [Related]
36. Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients.
Tang H; Wu Z; Zhang Y; Xia T; Liu D; Cai J; Ye Q
DNA Cell Biol; 2019 Dec; 38(12):1480-1498. PubMed ID: 31539276
[TBL] [Abstract][Full Text] [Related]
37. Liquid Biopsy for Monitoring EC Patients: Towards Personalized Treatment.
Piñeiro-Pérez R; Abal M; Muinelo-Romay L
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326558
[TBL] [Abstract][Full Text] [Related]
38. A Simplified Risk Stratification Method for Women With Stage I Endometrial Carcinoma.
Elshaikh MA; Modh A; Sakr S; Shrestha R; Burmeister C; Ali-Fehmi R; Hanna RK
Am J Clin Oncol; 2019 Feb; 42(2):131-137. PubMed ID: 30260801
[TBL] [Abstract][Full Text] [Related]
39. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.
Stelloo E; Nout RA; Osse EM; Jürgenliemk-Schulz IJ; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Nijman HW; Putter H; Bosse T; Creutzberg CL; Smit VT
Clin Cancer Res; 2016 Aug; 22(16):4215-24. PubMed ID: 27006490
[TBL] [Abstract][Full Text] [Related]
40. Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer.
Hveem TS; Njølstad TS; Nielsen B; Syvertsen RA; Nesheim JA; Kjæreng ML; Kildal W; Pradhan M; Marcickiewicz J; Tingulstad S; Staff AC; Haugland HK; Eraker R; Oddenes K; Rokne JA; Tjugum J; Lode MS; Amant F; Werner HM; Bjørge L; Albregtsen F; Liestøl K; Salvesen HB; Trovik J; Danielsen HE;
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):61-67. PubMed ID: 27587790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
